Related by context. All words. (Click for frequent words.) 73 relapsed MM 72 anthracycline taxane 71 Xelox 71 cisplatin gemcitabine 71 flutamide 70 paclitaxel cisplatin 70 galiximab 70 Pemetrexed 70 Folfox 70 Platinol ® cisplatin 70 lenalidomide Revlimid R 70 raloxifene Evista 70 LHRH receptor positive 70 MAGE A3 ASCI 70 docetaxel Taxotere 70 chemotherapy cisplatin 70 mitoxantrone plus 69 thromboembolisms 69 recurrent metastatic 69 adjuvant cisplatin 69 Femara letrozole 69 finasteride Proscar 69 Tarceva TM 69 gemcitabine carboplatin 69 tamoxifen Nolvadex ® 69 metastatic colorectal 69 antiandrogen 69 Xeloda ® 69 Hycamtin ® 69 oral clodronate 69 FUSILEV enhances 68 doxorubicin cyclophosphamide 68 ZACTIMA 68 letrozole Femara 68 oral chemotherapeutic agent 68 Mg Usa 68 Taxotere docetaxel 68 infliximab monotherapy 68 aspirin clopidogrel 68 sorafenib tablets 68 Camptosar ® 68 fibrate drugs 68 postoperative chemotherapy 68 Peginterferon alfa 2b 68 paclitaxel Taxol 68 prednisone prednisolone plus 68 estramustine 68 plus prednisone prednisolone 68 zoledronate 68 mycophenolate mofetil 68 papillary renal cell carcinoma 68 Alkeran 68 dalteparin 68 #mg #mg #mg [003] 68 zoledronic acid Reclast 68 stage IIIb IV 68 adalimumab Humira 67 achieved ACR# 67 liposomal doxorubicin 67 hormone receptor negative 67 MGd 67 Mg Uk 67 gemtuzumab ozogamicin 67 epoetin alpha 67 recurrent glioblastoma multiforme 67 underwent surgical resection 67 5 fluorouracil leucovorin 67 adriamycin 67 trastuzumab Herceptin ® 67 CYT# potent vascular disrupting 67 Vincristine 67 Sanofi Aventis Taxotere 67 #I TM# 67 dexamethasone Decadron 67 Hormone Refractory Prostate Cancer 67 pamidronate 67 oral rivaroxaban 67 5 Fluorouracil 67 Fulvestrant 67 Temsirolimus 67 Vidaza ® 67 cyclophosphamide methotrexate 67 cisplatin chemotherapy 67 Epirubicin 67 tinidazole 67 radiation chemoradiation 67 goserelin 67 microtubule inhibitor 67 deep venous thromboses 67 conjugated estrogen 67 anthracyclines taxanes 67 Temodar ® 67 concurrent chemoradiation 67 thalidomide Thalomid 67 carmustine 67 #mg ATC 66 metastatic colorectal carcinoma 66 Gemzar gemcitabine 66 mycophenolic acid 66 GnRH agonist 66 chemoradiation therapy 66 Interferon beta 1b 66 Taxotere chemotherapy 66 brivanib 66 Eli Lilly Gemzar 66 relapsing remitting MS RRMS 66 Iressa gefitinib 66 neutropenic sepsis 66 resectable pancreatic cancer 66 Her2 positive 66 demonstrated antitumor activity 66 mitoxantrone chemotherapy 66 cisplatin resistant 66 pegylated liposomal doxorubicin 66 Paraplatin ® 66 Arranon 66 capecitabine Xeloda 66 tenofovir emtricitabine 66 invasive lobular 66 tibolone 66 reduce serum phosphate 66 pain palliation 66 lymphomas leukemias 66 TAXOTERE R 66 comparator arm 66 achieved CCyR 66 sulfonylurea metformin 66 pravastatin Pravachol 66 adjuvant radiotherapy 66 biologic DMARD 66 sorafenib Nexavar 66 Arimidex anastrozole 66 taxane chemotherapy 66 atazanavir ritonavir 66 refractory chronic lymphocytic 66 aromatase inhibitor AI 66 Roche Xeloda 66 metastatic malignant 66 CIMZIA TM certolizumab pegol 66 ® lenalidomide 66 HMG CoA reductase inhibitors 66 radiolabeled TM# 66 Prolongs Survival 66 deCODE ProstateCancer TM 66 insulin glulisine 66 ritonavir boosted 66 Hycamtin 66 Leucovorin 66 erlotinib Tarceva ® 66 Intravenous immunoglobulin 66 docetaxel Taxotere R 65 IMiDs ® compound 65 Dementia Related Psychosis 65 liposome encapsulated 65 biliary tract cancer 65 Doxil ® 65 octreotide LAR 65 FOLFOX6 65 gefitinib Iressa 65 anthracycline chemotherapy 65 Ixempra 65 etanercept Enbrel 65 Neulasta R 65 TO AVOID PREGNANCY WHILE 65 Fludarabine 65 Faslodex 65 Celebrex celecoxib 65 PSMA ADC 65 5 FU leucovorin 65 pharmacologically active isomer 65 vincristine doxorubicin 65 Tykerb lapatinib 65 antidepressants fluoxetine 65 malignant ascites 65 REMINYL ® 65 tazobactam 65 antirheumatic 65 epirubicin cyclophosphamide 65 metastatic GIST 65 sulindac 65 CHOP chemotherapy 65 tamoxifen citrate 65 Panzem NCD 65 GnRH agonists 65 erlotinib Tarceva 65 progesterone receptor negative 65 recurrent epithelial ovarian 65 Proellex TM 65 nonnucleoside reverse transcriptase inhibitors 65 ixabepilone 65 antihormonal 65 ZOLINZA 65 #mg BID [001] 65 efavirenz EFV 65 Vidaza azacitidine 65 gadobutrol 65 treat enlarged prostate 65 Mitomycin C 65 FIRMAGON 65 Plaquenil 65 vinca alkaloid 65 Paraplatin ® carboplatin 65 abacavir lamivudine 65 daily subcutaneous injections 65 KRAS status 65 novel emulsion formulation 65 NSABP B 65 gemcitabine chemotherapy 65 interferon alfa 2b 65 microgram kg 65 dacarbazine chemotherapy 65 castrate resistant 65 medroxyprogesterone 65 vinca alkaloids 65 Targretin capsules 65 atorvastatin #mg 65 melphalan prednisone 65 metastatic gastric 65 INSPIRE Trial Phase III 65 Lilly Gemzar 65 recurrent NSCLC 65 clodronate 65 Pegylated Interferon 65 acyclovir Lauriad R 65 Exemestane 65 lenalidomide Revlimid 65 mg kg dose 65 chemosensitizer 65 eribulin mesylate 65 nucleotide analogue 65 mutated K ras 65 antiretroviral naïve 65 Gliadel Wafer 65 folinic acid 65 Azacitidine 65 Peg IFN 65 Teriflunomide 65 haematologic 65 cyclophosphamide doxorubicin vincristine 65 paclitaxel chemotherapy 65 gemcitabine Gemzar 65 vinorelbine tartrate 65 metastatic androgen independent 65 alkylating agent 64 non resectable metastatic 64 unfractionated heparin UFH 64 Taxol ® 64 assessing T DM1 64 gemcitabine cisplatin 64 Epivir HBV 64 evaluating tivozanib 64 azacytidine 64 Pertuzumab 64 YONDELIS 64 saquinavir ritonavir 64 interferon gamma 1b 64 novel VDA molecule 64 intravenous bisphosphonates 64 unresectable tumors 64 FASLODEX 64 TORISEL TM 64 antithymocyte globulin 64 ELOXATIN 64 medroxyprogesterone acetate 64 Cytoxan 64 nonmetastatic 64 myelodysplastic myeloproliferative diseases 64 Adjuvant chemotherapy 64 piroxicam 64 Paraplatin 64 postmenopausal osteoporotic women 64 Taxotere ® 64 baseline LDH 64 paclitaxel Taxol R 64 ara C 64 systemic ALCL 64 EOquin TM phase 64 infusional 5-FU/LV 64 metastatic bladder 64 hormone refractory metastatic prostate 64 Navelbine ® 64 weekly subcutaneous injections 64 Riluzole 64 certolizumab 64 ibandronate 64 fluvastatin 64 sargramostim 64 HER2 expression 64 standard chemotherapy regimen 64 CIMZIA ™ 64 humanised monoclonal antibody 64 antiresorptive 64 conjugated equine estrogen 64 irinotecan doxorubicin oxaliplatin paclitaxel 64 calcineurin inhibitor 64 bovine thrombin 64 peginterferon alpha 2a 64 docetaxel chemotherapy 64 adefovir dipivoxil 64 IMiDs ® 64 metastatic HER2 negative 64 fluorouracil leucovorin 64 BCIRG 64 boosted protease inhibitor 64 humanized therapeutic 64 lintuzumab SGN 64 AstraZeneca Arimidex 64 colorectal adenoma 64 cyclophosphamide chemotherapy 64 LungAlert TM 64 intradermal injections 64 placebo dexamethasone 64 GW# [003] 64 Ziprasidone 64 tipranavir ritonavir 64 alfa 2a 64 Afatinib 64 BoNTA 64 aripiprazole Abilify 64 azilsartan medoxomil 64 neratinib 64 conjugated estrogens 64 saline placebo 64 Orally administered 64 XELOX 64 alefacept 64 infusional 64 paclitaxel Taxol ® 64 untreated metastatic melanoma 64 Teriparatide 64 ovarian endometrial 64 RECORD1 64 Velcade bortezomib 64 bendamustine ifosfamide 64 chemotherapy FOLFOX 64 DEB# 64 docetaxel Taxotere ® 64 factor TNF 64 strontium ranelate 64 epoetin beta 64 oral antidiabetic medication 64 8mg/kg 64 SPRYCEL ® 64 EGFr expressing metastatic colorectal 64 relapsed ovarian cancer 64 lung pancreatic 64 bicalutamide 64 registrational Phase 64 ergot derivatives 64 advanced hepatocellular carcinoma 64 trabectedin 64 Gemcitabine 64 Nexavar sorafenib 64 low dose cytarabine 64 nilotinib Tasigna 64 NMIBC 64 metaglidasen 64 mg kg BID 64 tamoxifen Nolvadex 64 Aflibercept 64 Vandetanib 64 invasive lobular carcinoma 64 danazol 64 NATRECOR ® 64 inhibitor COX 64 HER2 overexpression 64 5-FU/LV 64 Accelerated Partial Breast Irradiation 64 Toremifene 64 FOLFOX chemotherapy 64 endometrial hyperplasia 64 cytarabine daunorubicin 64 Darinaparsin 64 VELCADE melphalan 64 vapreotide acetate 64 gastrointestinal stromal tumors GISTs 64 mg RDEA# 64 Neoadjuvant 64 clomipramine 64 allogeneic HSCT 64 Neulasta ® 64 Degarelix 64 recurrent malignant glioma 64 T1c 64 leuprorelin 63 Fluorouracil 63 steroid dexamethasone 63 iniparib BSI 63 epirubicin cisplatin 63 platelet aggregation inhibitors 63 anagrelide 63 ARIMIDEX 63 amoxicillin clavulanate 63 cilengitide 63 mycophenolate mofetil MMF 63 #mg/#mg 63 neoadjuvant therapy 63 idraparinux 63 ritonavir boosted lopinavir 63 FOLFIRI alone 63 anastrozole Arimidex 63 treatment naive genotype 63 NB S# strontium malonate 63 HER2 amplified 63 decompensated liver disease 63 Platinol ® 63 antineoplastic 63 nonsmall cell lung cancer 63 HBeAg negative patients 63 trastuzumab Herceptin R 63 R Saizen R 63 Triapine R 63 pegylated interferon alpha 63 lapatinib Tykerb 63 q8h 63 potent triglyceride lowering 63 advanced medullary thyroid 63 Dacogen decitabine 63 tenofovir Viread 63 Intravitreal 63 3TC lamivudine Epivir 63 Capecitabine 63 intravesical infusion therapy 63 3mg/kg 63 dasatinib Sprycel 63 Emtriva Viread 63 rFSH 63 Fondaparinux 63 CYP#D# inhibitor 63 pyrazinamide 63 Valcyte tablets 63 PLX STROKE targeting 63 bladder ovarian 63 resistant hormone refractory 63 alendronate Fosamax 63 biochemical relapse 63 plus dacarbazine 63 Fludara ® 63 Anastrozole 63 ZD# [001] 63 R sorafenib tablets 63 cortisol synthesis 63 anti androgen 63 R abatacept 63 undergoing hematopoietic stem 63 rizatriptan 63 anti Parkinsonian 63 prospectively stratified 63 Hepsera adefovir dipivoxil 63 desvenlafaxine succinate 63 FEMALES SHOULD BE ADVISED 63 Bevacizumab Avastin 63 CLL SLL 63 pegfilgrastim 63 acid phosphatase PAP 63 Pharmacokinetics PK 63 BARACLUDE ® 63 gastrointestinal stromal 63 Tarceva erlotinib 63 BRIM2 63 G#DT 63 pertuzumab 63 plus prednisone 63 Proleukin 63 Zorbtive TM 63 BCG refractory 63 tacrolimus ointment 63 Interferon beta 1a 63 tramiprosate Alzhemed TM 63 refractory indolent non 63 CYP#A# CYP#D# 63 VNP#M 63 sunitinib malate 63 Anthracycline 63 Aplidin 63 moderately emetogenic 63 dimeglumine 63 Irinotecan 63 mg clopidogrel 63 Topotecan 63 Flu Cy 63 Stage IIIb 63 PROSTVAC VF 63 Ceplene/IL-2 63 oral prednisone 63 cromolyn sodium 63 APTIVUS R 63 Hodgkin lymphoma HL 63 neoadjuvant 63 colorectal carcinomas 63 prednisone CHOP 63 mTOR inhibitors 63 Gemzar ® 63 Cellcept 63 tolterodine ER 63 prednisone prednisolone 63 AKT inhibitor 63 LymphoStat B belimumab 63 corticosteroid dexamethasone 63 Fludara 63 5 FU capecitabine 63 sipuleucel T 63 EXPLORE Xa 63 paricalcitol 63 receptor tyrosine kinase inhibitor 63 Parathyroid Hormone 63 Panzem R NCD 63 nodal metastasis 63 Recurrent Glioblastoma 63 PRN FDA Approves 63 metastatic pancreatic 63 QT QTc 63 nicardipine 63 leukotriene receptor antagonist 63 complete cytogenetic response 63 r hGH 63 cediranib 63 aspirin heparin 63 cilostazol 63 cisplatin vinorelbine 63 HER2 positive cancers 63 risedronate Actonel 63 containing drospirenone 63 Vidaza R 63 Bayer HealthCare Onyx Pharmaceuticals 63 pT2 63 whose tumors overexpress 63 mRCC 63 IFN α 63 verteporfin 63 ALN HPN 63 Ophena TM 63 K ras mutations 63 simvastatin ezetimibe 63 noninvasive outpatient 63 fallopian tube carcinoma 63 oral hypoglycemic agent 63 Patients Receiving 63 receiving SIMPONI 63 androgen suppression 63 advanced adenomas 63 bortezomib Velcade R 63 kidney urologic 63 MetroGel 63 ritonavir boosted atazanavir 63 hypereosinophilic syndrome 63 trastuzumab Herceptin 63 Xeloda capecitabine 63 IV Busulfex 63 COPEGUS R 63 intravenously administered 63 locoregional recurrence 63 chimeric monoclonal antibody 63 fusion enhancers 63 rosuvastatin Crestor 63 preoperative chemotherapy 63 KRAS mutations occur 63 fludarabine phosphate 63 evaluating Xcytrin 63 metastatic hormone refractory 63 interferon alfa 2a 63 sunitinib Sutent 63 subependymal giant cell 63 receiving INTRON 63 forodesine 63 irinotecan cisplatin 63 EURIDIS 63 Intravitreal injections 63 AZT zidovudine Retrovir 62 AVASTIN 62 darunavir r 62 NSCLC tumors 62 intratympanic 62 metastatic HRPC 62 benign prostatic hypertrophy 62 non mutated KRAS 62 FOSRENOL ® 62 weekly intravenous infusions 62 basiliximab 62 peritoneal cancer 62 temsirolimus 62 cisplatin carboplatin 62 phase III isavuconazole 62 progressive metastatic prostate 62 squamous histology 62 Epidermal Growth Factor Receptor 62 UCB Keppra 62 CIMZIA TM 62 noscapine 62 intravenous dosing 62 Pegasys peginterferon alfa 2a 62 NOLVADEX 62 neoadjuvant treatment 62 Trastuzumab DM1 62 mg subcutaneously 62 OvaRex MAb 62 luteinizing hormone releasing 62 pegaptanib 62 GRNOPC1 contains 62 Bezielle 62 PEG interferon 62 gemcitabine Gemzar ® 62 receiving highly emetogenic 62 prospective observational studies 62 Acetate Rectal Suppositories 62 iniparib 62 non hodgkin lymphoma 62 Combination REOLYSIN R 62 alfuzosin 62 Novo TTF 62 Adjuvant Treatment 62 intravenous REOLYSIN 62 parecoxib 62 sevelamer 62 chemoradiotherapy 62 MYLOTARG 62 histone deacetylase inhibitor 62 blood clot dissolving 62 Neupogen ® 62 intravenous immunoglobulin IVIg 62 brand ciclesonide HFA 62 BRCA1 BRCA2 62 estrogen ethinyl estradiol 62 Unstable Angina 62 topical testosterone 62 Cloretazine 62 beta carotene supplementation 62 progestagen 62 evaluating mipomersen 62 Angiotensin Converting Enzyme 62 interferon ribavirin 62 IgG1 monoclonal antibody 62 busulfan 62 β blockers 62 undergone radical prostatectomy 62 Dasatinib 62 #mg q8h 62 EOquin TM 62 ACE inhibitors beta blockers 62 pomalidomide 62 tumor xenograft models 62 imiquimod cream 62 alvespimycin 62 Subgroup analysis 62 nondiabetic patients 62 mertansine 62 advanced pancreatic neuroendocrine 62 Ribavirin causes 62 intradermal injection 62 CLARITY study 62 peginterferon alfa 2a Pegasys 62 Ovitrelle R Serostim 62 mutated KRAS 62 ethambutol 62 chronic HBV 62 thetreatment 62 Mitoxantrone 62 R# #mg BID 62 Soft Tissue Sarcoma 62 tarenflurbil 62 adjuvant trastuzumab 62 endocrine therapies 62 azathioprine monotherapy 62 Active Ulcerative Colitis 62 systemically administered 62 NovoTTF 62 taxane chemotherapy administered 62 mg TID 62 plus medroxyprogesterone acetate 62 Squamous 62 candesartan cilexetil 62 lanthanum carbonate 62 monoclonal antibody conjugated 62 aflibercept VEGF Trap 62 LHRH agonists 62 clobazam 62 lenalidomide dexamethasone 62 Telik logo TELINTRA 62 oblimersen 62 COMBIVIR 62 methotrexate monotherapy 62 Alimta pemetrexed 62 avosentan 62 subcutaneous enoxaparin 62 intravenous bolus 62 antiangiogenic therapy 62 hydroxymethyl coenzyme 62 pegylated alpha interferon 62 olmesartan 62 hormone LHRH antagonist 62 pretreatment serum 62 Natalizumab 62 Enzastaurin 62 bendamustine 62 carboplatin paclitaxel 62 chronically immunosuppressed solid 62 HER2 positive metastatic breast 62 CYP#A# substrate 62 lung cancer NSCLC 62 Chemoradiation 62 transdermal estradiol 62 oral ridaforolimus 62 nadolol 62 plus fludarabine 62 amifostine 62 sulfamethoxazole 62 pioglitazone HCl 62 recurrent metastatic ovarian cancer 62 HER2 ErbB2 62 Engerix B 62 etoposide 62 SMZ TMP 62 pegylated interferon alfa 62 GRNVAC1 62 mg hydrochlorothiazide 62 teriflunomide 62 CAELYX 62 mg Pycnogenol 62 rituximab Rituxan 62 induce remission 62 BRCA deficient 62 quadrivalent HPV vaccine 62 superficial basal cell carcinomas 62 degarelix 62 Tesmilifene 62 LHRH agonist 62 prucalopride 62 developed preclinically 62 AVOREN 62 Avandia Actos 62 acarbose 62 4mg/kg 62 human chorionic gonadotropin hCG 62 Hsp# Inhibitor 62 biologic antibody 62 Elotuzumab 62 alkylating 62 preoperative radiotherapy 62 fluorouracil 62 Known hypersensitivity 62 liposomal formulation 62 daunorubicin 62 sarcoma melanoma 62 beta blockers ACE inhibitors 62 Sandimmune 62 salmeterol fluticasone 62 CIN2 + 62 alkylating agents 62 flavopiridol 62 Gonal f 62 temozolomide TMZ 62 Thalomid ® 62 EGFR expressing 62 cetuximab Erbitux 62 cardiotoxic 62 Naive Patients 62 lasofoxifene 62 pancreatic prostate 62 meropenem 62 refractory gastrointestinal stromal 62 EGFR HER2 62 histologically confirmed 62 hoFH 62 terazosin 62 hepatic metastases 62 HGS ETR1 mapatumumab 62 Gleevec imatinib mesylate 62 taxane resistant 62 immunosuppressant drug 62 Boniva ibandronate 62 Vicinium TM 62 multicenter multinational 62 TPV r 62 HERCEPTIN 62 #mg/m# [002] 62 irinotecan oxaliplatin 62 cetuximab Erbitux R 62 lumiliximab 62 High Dose quadruples 62 receptor blocker 62 Amrubicin 62 budesonide pMDI 62 genotypic resistance 62 GnRH analogue 62 rituximab Rituxan ® 62 Tumor Response 62 BEXXAR Therapeutic Regimen 62 dasatinib Sprycel ® 62 Pegylated interferon 62 Trabectedin 62 terfenadine 62 partial remissions 62 Indomethacin 62 receptor inhibitor 62 Bicalutamide 62 accumulate preferentially 62 bolus dose 62 FluCAM arm 62 lipid lowering agents 62 MKC# MT 62 Ellence 62 Trinovin 62 mg QD 62 Cefazolin 62 oropharyngeal candidiasis OPC 62 pharmacokinetic interactions 62 rufinamide 62 irbesartan 62 ziprasidone Geodon 62 Oxaliplatin 62 IRESSA 62 containing LABAs 62 Budesonide foam crofelemer 62 epirubicin 62 Theratope 62 statin cholesterol lowering 62 DU #b 62 infused intravenously 62 BZA CE 62 antiangiogenic agents 62 FOLPI 62 imexon 62 selective modulator 62 transarterial 62 Vectibix panitumumab 62 hA# 62 evaluating satraplatin 62 unresectable HCC 61 Losartan 61 IXEMPRA 61 CYT# QbG# 61 Navelbine 61 immune modulating 61 follicular lymphoma FL 61 argatroban 61 potentially hepatotoxic 61 histologic subtype 61 cancer mCRC 61 interferon IFN 61 BR.# 61 Pivotal Phase III 61 doxazosin 61 deCODE AF TM 61 RhuDex R 61 CTAP# Capsules 61 IMiDs R 61 oral deforolimus 61 bortezomib Velcade 61 IIIa inhibitor 61 Sprycel dasatinib 61 Seroquel quetiapine fumarate 61 plus COPEGUS 61 fulvestrant 61 Posaconazole 61 histologies 61 autoantibody positive 61 sitaxsentan 61 peginterferon alfa 2b 61 octreotide acetate 61 6 mercaptopurine 61 mcg BID 61 alpha 2a 61 Erbitux cetuximab 61 androgen receptor antagonist 61 HCV replicon 61 dose dexamethasone 61 lipid lowering drugs 61 PD LID 61 PSA nadir 61 glulisine 61 Pfizer Camptosar 61 piperacillin tazobactam 61 oseltamivir Tamiflu ® 61 myopathy rhabdomyolysis 61 Mylotarg 61 inhibit EGFR 61 Sanofi Pasteur Fluzone 61 chemotherapeutic regimen 61 intravenous cyclophosphamide 61 zoledronic acid Zometa 61 Noxafil 61 beta estradiol 61 prospectively randomized 61 5alpha reductase 61 Mycophenolate Mofetil 61 irinotecan hydrochloride 61 APTIVUS 61 tigecycline 61 Cloretazine ® 61 PegIntron 61 ovarian pancreatic 61 ALIMTA cisplatin 61 operable breast cancer 61 leflunomide 61 metformin sulfonylurea 61 substantially excreted 61 pegylated IFN 61 Raloxifene STAR 61 Amgen Neulasta ® 61 nonvertebral fractures 61 Pegylated Liposomal Doxorubicin 61 MYCAMINE 61 FOLFOX4 61 advanced metastatic prostate 61 malignancy HCM 61 albiglutide 61 titrated glipizide 61 AROMASIN 61 Amgen Neulasta R 61 bezafibrate 61 pentoxifylline 61 KRAS mutant tumors 61 debulking surgery 61 colorectal pancreatic 61 Levoleucovorin 61 fallopian tube cancers 61 albumin bound paclitaxel 61 visilizumab 61 HCV RESPOND 2 61 pregabalin Lyrica 61 Hydrochlorothiazide 61 chemoresistant 61 Predict Response 61 ORENCIA ® 61 lumbar spine BMD 61 Viread Emtriva 61 RoACTEMRA 61 budesonide foam 61 mapatumumab 61 #mg doses [002] 61 Platinol 61 briakinumab 61 1mg 2mg 61 oral diclofenac 61 resected pancreatic cancer 61 salmeterol fluticasone propionate 61 Fluconazole 61 papillary carcinoma 61 LEUKINE 61 chemotherapeutic agents carboplatin 61 hematopoietic cancers 61 PEGINTRON TM 61 CTAP# 61 taxane therapy 61 metastatic neuroendocrine tumors 61 Onrigin 61 TDF FTC 61 ELACYT 61 lymphoid malignancies 61 injected subcutaneously 61 Glatiramer acetate 61 hormonally sensitive 61 receiving prophylactic anticoagulation 61 abacavir Ziagen 61 riociguat 61 invasive ductal 61 non valvular atrial 61 #mg BID [003] 61 antitumor effect 61 RRM1 61 Lipitor #mg 61 mesylate 61 docetaxel prednisone 61 bevacizumab Avastin ® 61 INVANZ 61 patients receiving myelosuppressive 61 blinded randomized placebo controlled 61 intraperitoneally 61 severe hypersensitivity reactions 61 Mestinon 61 radiotherapy RT 61 PhG alpha 1 61 5FU 61 efalizumab 61 EGFR expressing mCRC 61 STELARA ™ 61 glatiramer acetate 61 ErbB2 positive 61 administered intranasally 61 Cenestin 61 REYATAZ R 61 mcg doses 61 antiangiogenic agent 61 GVAX Pancreas Vaccine 61 metastatic renal 61 EndoTAGTM 1 61 adenosine injection 61 divalproex sodium 61 miconazole Lauriad ® 61 hyperphenylalaninemia HPA due 61 ovarian breast 61 AZT 3TC 61 vincristine sulfate 61 Daclizumab 61 CDK4 61 Decadron 61 demethylating agent 61 selective estrogen receptor modulator 61 inhibit platelet function